Inductive Places First in OpenADMET CYP Inhibition Challenge, Its Fourth Consecutive AI Drug Discovery Benchmark Win

Markets PR Newswire By PR Newswire 06 Nov 2026 16:00 1 min read
Inductive Places First in OpenADMET CYP Inhibition Challenge, Its Fourth Consecutive AI Drug Discovery Benchmark Win

Inductive's Beacon models top 270+ participants, including teams from NVIDIA and Recursion, in the CYP Direct Inhibition Challenge NEW YORK, Nov. 6, 2026 /PRNewswire/ -- Inductive, the chemical intelligence organization for drug discovery, placed first in the OpenADMET CYP Direct...

Covered in this story

Call it yourself

No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on NOV →

Dalsna Finance is currently tracking 108 stories mentioning NOV, the earliest published 7 Oct 2025.

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.